Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Total Brain Limited
  6. News
  7. Summary
    TTB   AU0000032435

TOTAL BRAIN LIMITED

(TTB)
  Report
Delayed Australian Stock Exchange  -  11:46 2022-12-04 pm EST
0.0400 AUD    0.00%
11/01SonderMind Inc. acquired Assets of Total Brain Limited.
CI
10/31Total Brain Completes Business Asset Sale to SonderMind; Shares Up 5%
MT
10/30Transcript : Total Brain Limited - Shareholder/Analyst Call
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Total Brain : Notification regarding unquoted securities - TTB

04/10/2022 | 10:09pm EST

Announcement Summary

Entity name

TOTAL BRAIN LIMITED

Date of this announcement Monday April 11, 2022

The +securities the subject of this notification are:Other

Total number of +securities to be issued/transferredASX +securityTotal number of +securities to be

code

Security description

issued/transferred

Issue date

New class - code

Convertible notes

1,278,485

08/04/2022

to be confirmed

Refer to next page for full details of the announcementPart 1 - Entity and announcement details

1.1 Name of entity TOTAL BRAIN LIMITED

We (the entity named above) give notice of the issue, conversion or payment up of the following unquoted +securities.

1.2 Registered number type ACN

1.3 ASX issuer code TTB

1.4 The announcement isNew announcement

1.5 Date of this announcement 11/4/2022

Registration number 094069682

Part 2 - Issue details

2.1 The +securities the subject of this notification are:

Other

Please specify

Unquoted convertible notes announced in Appendix 3B on 5 April 2022

2.2a This notification is given in relation to an issue of +securities in a class which is not quoted on ASX and which:does not have an existing ASX security code ("new class")

Part 3C - number and type of +securities the subject of this notification (new class) where issue has not previously been notified to ASX in an Appendix 3B

New +securities

ASX +security code

New class - code to be confirmed

+Security descriptionConvertible notes

+Security type

ISIN code

+Convertible debt securities

Date the +securities the subject of this notification were issued 8/4/2022

Will all the +securities issued in this class rank equally in all respects from their issue date?

Yes

Have you received confirmation from ASX that the terms of the +securities are appropriate and equitable under listing rule 6.1?

No

Please provide a URL link for a document lodged with ASX setting out the material terms of the +securities being issued. https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02507035-2A1367035?access_token=83ff96335c2d45a094df02a206a39ff4

+Convertible debt securities Details

Type of +security Convertible note or bond

+Security currency

Face value

Interest rate type

AUD - Australian Dollar

AUD 1.00000000

Fixed rate

Frequency of coupon/interest payments per year

No coupon/interest payments

s128F of the Income Tax Assessment Act status applicable to the +security s128F exemption status unknown

Is the +security perpetual (i.e. no maturity)?

No

Maturity date

8/10/2023

Select other feature(s) applicable to the +security

Convertible

In what currency was the cash consideration being

What was the issue price per +security?

paid?

AUD - Australian Dollar

AUD 1.00000000

Purpose of the issue

To fund the retirement of debt

Notification of Issue, Conversion or Payment up of Unquoted

5 / 7

Equity Securities

Is there a first trigger date on which a right of conversion, redemption, call or put can be exercised (whichever is first)?

No

Details of the existing class of +security that will be issued if the securities are converted, transformed or exchanged

Other

Description

TTB Ordinary Fully Paid

Any other information the entity wishes to provide about the +securities the subject of this notification

Please provide any further information needed to understand the circumstances in which you are notifying the issue of these +securities to ASX, including why the issue of the +securities has not been previously announced to the market in an Appendix 3B

Unquoted convertible notes announced in Appendix 3B on 5 April 2022

Issue details

Number of +securities

1,278,485

Were the +securities issued for a cash consideration?

Yes

This is an excerpt of the original content. To continue reading it, access the original document here.

Disclaimer

Total Brain Limited published this content on 11 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 April 2022 02:08:03 UTC.


ę Publicnow 2022
All news about TOTAL BRAIN LIMITED
11/01SonderMind Inc. acquired Assets of Total Brain Limited.
CI
10/31Total Brain Completes Business Asset Sale to SonderMind; Shares Up 5%
MT
10/30Transcript : Total Brain Limited - Shareholder/Analyst Call
CI
09/30Total Brain : Annual Report FY2022 (PDF)
PU
09/30Total Brain : AGM Online Shareholders Meeting Guide 2022
PU
09/30Total Brain Limited Auditor Raises 'Going Concern' Doubt
CI
09/29Total Brain : TTB 2022 AGM Notice of Meeting
PU
08/30Total Brain Limited Reports Earnings Results for the Full Year Ended June 30, 2022
CI
08/05Total Brain Agrees to Salell Business for $10 Million
MT
08/05SonderMind Inc. entered into an agreement to acquire Assets of Total Brain Limited for ..
CI
More news
Financials
Sales 2022 8,42 M 5,71 M 5,71 M
Net income 2022 -14,5 M -9,83 M -9,83 M
Net Debt 2022 0,50 M 0,34 M 0,34 M
P/E ratio 2022 -0,41x
Yield 2022 -
Capitalization 5,35 M 3,63 M 3,63 M
EV / Sales 2021 9,86x
EV / Sales 2022 0,79x
Nbr of Employees 29
Free-Float 59,3%
Chart TOTAL BRAIN LIMITED
Duration : Period :
Total Brain Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TOTAL BRAIN LIMITED
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 0
Last Close Price 0,04
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Matthew Mund Chief Executive & Operating Officer
Evian Gordon Executive Chairman & Chief Medical Officer
Donna Palmer Chief Science Officer
Matthew Morgan Non-Executive Director
David Torrible Non-Executive Director